Cargando…
The Risk of Emerging Resistance to Trimethoprim/Sulfamethoxazole in Staphylococcus aureus
OBJECTIVE: Due to the spread of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), the demand for trimethoprim/sulfamethoxazole (SXT) is increasing in the world. It is not clear whether the resistant strain emerges by overuse of SXT. We investigated here the emergent risk of t...
Autores principales: | Sato, Takumi, Ito, Ryota, Kawamura, Masato, Fujimura, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419895/ https://www.ncbi.nlm.nih.gov/pubmed/36039323 http://dx.doi.org/10.2147/IDR.S375588 |
Ejemplares similares
-
Phenotypic Detection of Hemin-Inducible Trimethoprim-Sulfamethoxazole Heteroresistance in Staphylococcus aureus
por: Nurjadi, Dennis, et al.
Publicado: (2021) -
Osteomyelitis due to methicillin-resistant Staphylococcus
aureus successfully treated by an oral combination of minocycline
and trimethoprim–sulfamethoxazole
por: Sato, Kojiro, et al.
Publicado: (2019) -
Ceftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis
por: Fabre, Valeria, et al.
Publicado: (2014) -
Integrative Analysis of Whole Genome Sequencing and Phenotypic Resistance Toward Prediction of Trimethoprim-Sulfamethoxazole Resistance in Staphylococcus aureus
por: Nurjadi, Dennis, et al.
Publicado: (2021) -
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
por: Paul, Mical, et al.
Publicado: (2015)